| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 01/03/2003 | WO2002026209A3 Microparticles for delivery of the heterologous nucleic acids |
| 01/03/2003 | WO2002008264A3 Papillomavirus infected epithelial cells and methods of producing infectious papillomavirus in epithelial cells and uses thereof |
| 01/03/2003 | CA2454882A1 Chimeric capsid proteins and uses thereof |
| 01/03/2003 | CA2451864A1 Methods of inducing a cytotoxic immune response and recombinant simian adenovirus compositions useful therein |
| 01/03/2003 | CA2451437A1 Production of infectious hepadnavirus particles containing foamy retrovirus envelope proteins and methods of using the same |
| 01/02/2003 | US20030003567 Packaging cells |
| 01/02/2003 | US20030003566 Cell line preparing and producing ovine adenovirus vectors |
| 01/02/2003 | US20030003448 Method |
| 01/02/2003 | US20030003447 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| 01/02/2003 | US20030003443 Designation MVP-5180/91, deposited with the European Collection of Animal Cell Cultures under No V 920 92 318 |
| 01/02/2003 | US20030003442 Retrovirus from the HIV group and its use |
| 01/02/2003 | US20030003112 Avipox virus containing foreign DNA from porcine reproductive and respiratory syndrome virus; immunological compositions containing the recombinant poxvirus for inducing an immunological response in a host animal |
| 01/02/2003 | US20030003080 Reovirus for the treatment of cellular proliferative disorders |
| 01/02/2003 | US20030003079 Recombinant pox virus for immunization against tumor-associated antigens |
| 01/02/2003 | US20030003076 Adenovirus E1B-55K single amino acid mutants and methods of use |
| 01/02/2003 | EP1270586A2 Composition for the cell-specific transfer of active substances |
| 01/02/2003 | EP1270016A1 Aids virus vaccine with the use of sendai virus vector |
| 01/02/2003 | EP1268851A1 Method of concentrating and recovering a viral enzyme activity from biological samples |
| 01/02/2003 | EP1268833A2 Modified nodavirus rna for gene delivery |
| 01/02/2003 | EP1268766A2 Improvements to ribosome display |
| 01/02/2003 | EP1268761A2 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof |
| 01/02/2003 | EP1268750A1 Improved methods to isolate, identify, quantify, and propagate chicken infectious anemia virus and high titer vaccine |
| 01/02/2003 | EP1268749A1 Diagnostic reagents and methods for antibody against hepatitis b surface antigen and for antibody against hepatitis b virus |
| 01/02/2003 | EP1268748A1 Method of producing adenoviral vector stocks |
| 01/02/2003 | EP1268550A2 Human fap-alpha-specific antibodies |
| 01/02/2003 | EP1268524A2 Binding peptides for carcinoembryonic antigen (cea) |
| 01/02/2003 | EP1267920A2 Cold-adapted equine influenza viruses |
| 01/02/2003 | EP1267626A1 Recombinant parainfluenza virus expression systems and vaccines |
| 01/02/2003 | EP0979284B1 Reagents for vaccination which generate a cd8 t cell immune response |
| 01/01/2003 | CN1388829A High efficiency retroviral vector which contains genetically engineered cellular non-coding sequence harboring splicing acceptor |
| 01/01/2003 | CN1097633C Determinating, purifying and testing for rhabdovirus of ichthyophthirius |
| 12/31/2002 | US6500800 Composition and method for causing photodynamic damage to target cells |
| 12/31/2002 | US6500663 Unique associated Kaposi's sarcoma virus sequences and uses thereof |
| 12/31/2002 | US6500662 Infectious cdna clones of positive polarity rna viruses and the construction of vaccines, in particular, swine vaccines, using such cdna clones |
| 12/31/2002 | US6500639 DNA shuffling to produce nucleic acids for mycotoxin detoxification |
| 12/31/2002 | US6500623 Pseudotyped with vesicular stomatitis virus g protein; modifying portion of the pol gene of dna molecule that includes a complete retroviral genome such that it cannot produce a protease and reverse transcriptase |
| 12/31/2002 | US6500611 Inviable virus particles as scaffolds for constructing flexible detection systems |
| 12/27/2002 | WO2002103012A1 Chimaeric phages |
| 12/27/2002 | WO2002102999A1 Attenuated circovirus |
| 12/27/2002 | WO2002102828A2 Chimeric flavivirus vectors |
| 12/27/2002 | WO2002072852A3 Leporipox-based vector vaccines |
| 12/27/2002 | WO2002057302A3 A virus causing respiratory tract illness in susceptible mammals |
| 12/27/2002 | WO2002029075A8 Multiple inducible gene regulation system |
| 12/27/2002 | WO2002029065A3 Retroviral vectors containing internal ribosomal entry sites |
| 12/27/2002 | WO2002010379B1 Modified cea and uses thereof |
| 12/27/2002 | CA2448971A1 Chimeric flavivirus vectors |
| 12/26/2002 | US20020197714 Composition and method for increasing cell density in cell cultures infected with lentivirus |
| 12/26/2002 | US20020197711 Coxsackievirus B4 expression vectors and uses thereof |
| 12/26/2002 | US20020197705 Mutant cells; for propagation of influenza virus mutants |
| 12/26/2002 | US20020197700 Receptor of the EDb-fibronectin domains |
| 12/26/2002 | US20020197277 Cell culture system for synthesis of infectious hepatitis C virus |
| 12/26/2002 | US20020197264 Protecting against canine oral papillomavirus (COPV) |
| 12/25/2002 | CN1387574A Gene transfer method |
| 12/24/2002 | US6498244 Adeno-associated virus capsid immunologic determinants |
| 12/24/2002 | US6498033 Retroviral vector with gag gene sequence containing packaging signal; human immunodeficiency virus treatment; vaccines; gene therapy; anticarcinogenic agents |
| 12/24/2002 | US6498027 Virus-like particle or gene delivery vehicle |
| 12/24/2002 | US6498008 Method for detecting swine infertility and respiratory virus |
| 12/24/2002 | US6497884 Viable chimeric recombinant flavivirus comprising region of nucleic acid encoding premembrane and envelope structural proteins of langat virus linked to region of nucleic acid encoding non-structural proteins of dengue type 4 virus |
| 12/24/2002 | US6497883 Porcine circovirus recombinant poxvirus vaccine |
| 12/24/2002 | US6497882 Virus comprising foreign dna inserted into swinepox virus genome within specified region, which is capable of being expressed in host cell into which virus is introduced |
| 12/24/2002 | US6497873 Rhabdovirus comprising heterologous fusion protein which facilitates fusion of rhabdovirus to target cell membrane, heterologous g stem polypeptide, rhabdovirus n, p and l proteins, deletion of nucleotide sequence encoding g protein |
| 12/19/2002 | WO2002100340A2 Improved vaccination against anthrax |
| 12/19/2002 | WO2002074243A3 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders |
| 12/19/2002 | WO2002070565A3 High-affinity antagonists of elr-cxc chemokines |
| 12/19/2002 | WO2001072994A9 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof |
| 12/19/2002 | WO2001070032A9 Recombinant parainfluenza virus expression systems and vaccines |
| 12/19/2002 | WO2001068859A9 Il-17 receptor like molecules and uses thereof |
| 12/19/2002 | WO2001004335A3 Human-bovine chimeric respiratory syncytial virus vaccines |
| 12/19/2002 | US20020193565 Antigen preparation and use |
| 12/19/2002 | US20020192825 Methods of use of viral vectors to deliver antigen to dendritic cells |
| 12/19/2002 | US20020192824 Viral vectors having chimeric envelope proteins containing the IgG-binding domain of protein A |
| 12/19/2002 | US20020192802 Replication competent herpes virus strains |
| 12/19/2002 | US20020192689 Detection of preferential nucleotidse sequences; obtain sample, incubate with probe, detect signal, recover nucleotide sequences |
| 12/19/2002 | US20020192640 Purified active HCV NS2/3 protease |
| 12/19/2002 | US20020192234 Antigen strain in vehicle; inducting immunology response |
| 12/19/2002 | US20020192226 Production of a parvovirus vaccine in plants as viral coat protein fusions |
| 12/19/2002 | US20020192185 Recombinant protein production in bovine adenovirus expression vector system |
| 12/18/2002 | EP1266036A1 Methods and compositions for identifying a protease |
| 12/18/2002 | EP1266022A2 Cell-specific adenovirus vectors comprising an internal ribosome entry site |
| 12/18/2002 | EP1266020A2 Production of foreign polypeptides in plants as viral coat protein fusions |
| 12/18/2002 | EP1266002A2 Il-17 receptor like molecules and uses thereof |
| 12/18/2002 | EP1265989A2 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis |
| 12/18/2002 | EP1265480A1 Chimeric animal model susceptible to human hepatitis c virus infection |
| 12/18/2002 | CN1385440A Protein molecule with function for inhibiting I type simple herpesvirus replication and its preparation method |
| 12/17/2002 | US6495361 Method of producing infectious papillomavirus in placental cells |
| 12/17/2002 | US6495360 Increasing production yield of viruses, viral proteins, and other related biological materials through enhanced control and stabilization of protein production via stress proteins; permissive eukaryotic cell lines |
| 12/17/2002 | US6495349 Chimeric gene constructs |
| 12/17/2002 | US6495316 Cells suitable for the detection of herpes virus, wherein said cells comprise mrc-5 cells and cv-1 cells |
| 12/17/2002 | US6495315 Channel forming toxins as antiviral agents |
| 12/17/2002 | US6495143 Inducing immunology response |
| 12/12/2002 | WO2002099101A1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes |
| 12/12/2002 | WO2002099035A2 Chimeric alphavirus replicon particles |
| 12/12/2002 | WO2002086072A8 Antimicrobial polypeptides and their uses |
| 12/12/2002 | WO2002079239A9 Chimeric filovirus glycoprotein |
| 12/12/2002 | WO2001027303A9 Adeno-associated virus vectors encoding factor viii and methods of using the same |
| 12/12/2002 | US20020187929 Inactivating process for lipid envelopped virus, and new antivirus lipopeptides |
| 12/12/2002 | US20020187465 Treatment of cell proliferative disorders; obtain human, administer antiproliferative agent, monitor humans for reduction in tumor cells |
| 12/12/2002 | US20020187163 Herpes simplex virus comprising a mutation within the BstEII-EcoNI fragment of the BamHI x fragment of said virus; cancer vaccine |
| 12/12/2002 | US20020187153 Immunotoxins, comprising an internalizing antibody, directed against malignant and normal cells |
| 12/12/2002 | US20020187128 Novel replication deficient adenovirus vectors and methods for making and using them |